It isn’t clear what’s driving the shift, but scientists suspect that environmental exposures may be partially to blame.

Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun. Gastrointestinal stromal tumor (GIST) is a rare type of ...

A session at United European Gastroenterology (UEG) Week 2025 shined a spotlight on the emerging role of the gut microbiome in gastrointestinal (GI) cancer. From the stomach to the colon, manipulating ...

The BREAKWATER trial demonstrated the efficacy of a BRAF-targeted regimen using FOLFIRI, offering a neuropathy-free option for metastatic colorectal cancer patients. HERIZON-GEA-01 trial results ...

Please provide your email address to receive an email when new articles are posted on . Genetic testing can be accomplished for most patients with gastrointestinal cancer prior to starting ...

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, British Columbia, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The FDA approved the first perioperative immunotherapy ...

You don’t get colon cancer during your 30s or 40s, right? Wrong. Rising rates of colorectal cancer among younger generations show otherwise. This was brought home when actor James Van Der Beek died ...

Attending my great friend (and great journalist) Al Weaver’s bachelor trip to Chicago last summer, I met Ryan Tilley. Ryan is ...

Colorectal cancer prevention and maintaining gastrointestinal health have never been more important. Dr. Tanya Evans, a leading gastroenterologist, shares essential advice on screenings, GI disorders, ...

Detailed price information for Oncolytics Biotech Inc (ONCY-Q) from The Globe and Mail including charting and trades.